We investigated the role of cholinergic neurotransmission in olfactory fear learning. Mice receiving pairings of odor and foot shock displayed fear to the trained odor the following day. Pretraining injections of the nicotinic antagonist mecamylamine had no effect on subsequent freezing, while the muscarinic antagonist scopolamine significantly reduced freezing. To test whether cholinergic manipulation affected fear generalization, mice were presented with odors similar to the trained odor. Generalization was increased following pretraining scopolamine, while the muscarinic agonist oxotremorine decreased generalization. These results suggest that muscarinic neurotransmission during the acquisition of olfactory association modulates both the strength and specificity of learning.
The olfactory system receives cholinergic input from the horizontal limb of the diagonal band of Broca (HDB) (Zaborszky et al. 1986 ). Blocking olfactory system cholinergic receptors disrupts several aspects of olfactory processing including olfactory shortterm memory (Hunter and Murray 1989; Paolini and McKenzie 1993; Miranda et al. 2009 ), perceptual learning, and discrimination (Ravel et al. 1992; Fletcher and Wilson 2002; Linster and Cleland 2002; Mandairon et al. 2006) . Despite this, relatively little is known about the role of cholinergic activation during acquisition of olfactory aversive learning. While a recent study has demonstrated that cholinergic blockade during acquisition reduces odor-evoked displays of defensive responses to the learned odor (Kroon and Carobrez 2009) , the cholinergic contribution to the magnitude and specificity of olfactory fear learning is currently unknown.
Sensory cue-evoked fear conditioning has long been used in the study of the neural mechanisms underlying associative memory. In the standard fear-conditioning paradigm, a neutral stimulus is associated with an aversive foot shock, allowing the conditioned stimulus to acquire an aversive valence and induce fear responses, such as freezing (LeDoux 2003) . Olfactory cues have been used as an effective conditioned stimulus in promoting fear-conditioned responses (Otto et al. 2000; Jones et al. 2005; Kroon and Carobrez 2009) and studies in other sensory systems have shown that cholinergic neurotransmission is involved in fear learning (Tinsley et al. 2004 ). For example, in auditory-cued fear conditioning, blockade of muscarinic receptors disrupts the acquisition of the tone-fear conditioning (Young et al. 1995; Anagnostaras et al. 1999; Feiro and Gould 2005) , while blocking nicotinic activation does not affect this learning (Feiro and Gould 2005) . Despite this, it remains to be seen whether nicotinic and muscarinic receptors can also mediate conditioned freezing responses to olfactory stimuli.
In this study, we found that pretraining injections of the nicotinic receptor antagonist (nAChR) mecamylamine had no effect on olfactory fear learning. However, pretraining injections of the muscarinic antagonist scopolamine (mAChR) significantly reduced freezing to the trained odor in a dose-dependent manner, suggesting that muscarinic activation is important for the acquisition of olfactory fear learning. We next tested whether manipulation of mAChRs could also affect the specificity of the fear learning. In this case, mice trained to a single odor tend to freeze at similar levels when tested with other structurally similar odors, a phenomenon known as generalization. Overall, we find that generalization is increased following pretraining injections of scopolamine, while pretraining injections of the mAChR agonist oxotremorine decreased the amount of generalization.
Experiments were performed on adult male and female C57BL/6J mice (n ¼ 172) and were approved by the University of Tennessee Institutional Animal Care and Use Committee. Mice were group housed with food and water available ad libitum. Methyl scopolamine, scopolamine hydrobromide, mecamylamine, and oxotremorine (Sigma-Aldrich) were dissolved in saline with doses based on previous studies (Castellano and McGaugh 1991; Feiro and Gould 2005) . All injections were administered intraperitoneally at 5 mL/g 10 min before training. Higher doses of mAChR agonists can cause increased nasal secretions, possibly affecting olfactory-guided behaviors. To avoid this, mice receiving injections of oxotremorine also received the blood-brain barrier impermeant muscarinic antagonist, methyl scopolamine. Previous studies have shown that injections of m-scopolamine have no effect on fear conditioning (Rudy 1996; Anagnostaras et al. 1999) . We found that control mice injected with methyl scopolamine alone prior to training displayed freezing levels similar to control levels during testing (M-scop mean freezing ¼ 65.26 + 5.7%; Saline mean freezing ¼ 67.84 + 5.9%; t-test: t (11) ¼ 0.29, P ¼ 0.77).
All mice were trained inside a mouse test cage equipped with a floor of parallel steel bars connected to a shocker (Coulbourn Instruments). Before training, mice were placed in the chamber for a 10-min habituation period. Conditioning took place in a single session of six trials of a 10-sec ethyl valerate (E5) presentation followed by 0.25-sec, 0.4 mA foot shocks. Trials were separated by an ITI of 2 min. Following training, mice were placed back into their home cages until testing the following day.
The next day, mice were placed in a different test chamber with a Plexiglas floor (Med Associates) for a 5-min habituation period. Following habituation, mice received five 20-sec presentations of the test odorant at 1-min intervals, starting at the second minute. Each session was recorded and analyzed using FreezeFrame software (Coulbourn Instruments). Learning was quantified by freezing, defined as the absence of all motor activity in the presence of the cue (Fanselow and Bolles 1979) , lasting for at least 2 sec and expressed as the percent time freezing per minute.
Odorants were presented through separate lines into the side of the chambers at 1 L/min using an olfactometer. Ethyl butyrate (E4), ethyl valerate (E5), and ethyl hexanoate (E6) (Sigma-Aldrich) were dissolved in mineral oil to achieve an approximate headspace concentration of 200 ppm. Statistical significance was determined by one-way ANOVA and post hoc Dunnett's tests using Prism software (GraphPad Software). Error values are reported as
To analyze the effect of E5 odor in fear-conditioned responses, mice were presented with E5 during the test session. A significant training-condition effect was detected in the percentage of freezing (ANOVA: F (2,18) ¼ 57.98, P , 0.05) with mice in the paired group displaying high levels of freezing (61.38 + 5.4%) (n ¼ 10), while mice in the odor only (0.00 + 0%) (n ¼ 3) and shock only (3.73 + 1.8%) (n ¼ 7) groups froze very little. Post hoc analysis revealed a significant difference in freezing responses between the paired group and the odor only (P , 0.05) and the shock only (P , 0.05) group (Fig. 1) .
To evaluate the role of m-and nAChRs in the acquisition of conditioned fear, mice received injections of the mAChR antagonist scopolamine (0.05, 0.5, or 5 mg/kg) or the nAChR antagonist mecamylamine (1, 2, or 5 mg/kg) before being placed in the chamber. All groups were trained to E5 and tested with E5 on the following day. For mecamylamine, no statistical differences in freezing times were detected at any dose compared with those receiving saline injections (ANOVA: F (3,13) ¼ 0.38, P ¼ 0.77) ( Fig. 2A ). (saline: 65.24 + 9.6%, n ¼ 4; 1 mg/kg: 63.52 + 7.4%, n ¼ 4; 2 mg/kg: 77.46 + 9.1%, n ¼ 4; 5 mg/kg: 65.38 + 12.3%, n ¼ 5). For scopolamine, a significant treatment effect was detected between groups in the amount of freezing during testing (ANOVA: F (3,22) ¼ 9.62, P , 0.05). Pretraining scopolamine injections of 0.5 and 5 mg/kg decreased the amount of freezing during testing as post hoc analysis revealed significant differences between the saline and 0.5 mg/kg (P , 0.05) and the saline and 5 mg/kg groups (P , 0.05) (Fig. 2B ). (saline: 70.43 + 8.1%, n ¼ 4; 0.05 mg/kg: 67.54 + 7.1%, n ¼ 8; 0.5 mg/kg: 31.64 + 5.2%, n ¼ 5; 5 mg/kg: 33.80 + 5.3%, n ¼ 9).
To determine how learned fear to E5 would generalize to other structurally similar odorants, all mice were trained to E5, but on the following day were placed into three groups. One group was presented with the trained odorant E5; one group with ethyl butyrate (E4), a similar ethyl ester containing one less carbon; and another group with ethyl hexanoate (E6), a similar ethyl ester with one more carbon. Following training, mice presented with E5 during testing displayed similar freezing responses compared with mice in the control experiment (68.5 + 7.5%, n ¼ 8). Mice presented with E4 froze 37.77 + 7.1% (n ¼ 8), and mice presented with E6 froze 41.44 + 9.5% (n ¼ 10). A significant odor effect was detected between groups during the generalization test (ANOVA: F (2,23) ¼ 3.75, P , 0.05). Post hoc analysis revealed a significant difference in freezing responses between the E4 group and the E5 group only (P , 0.05) (Fig. 3A) , suggesting that mice generalize their fear of E5 to the longer chained E6, but not to the shorter chained E4.
Since blocking mAChRs disrupted learning in our scopolamine study, we next tested whether pretraining scopolamine would also effect fear generalization. The generalization experiment was repeated, with the exception that all mice received Cholinergic modulation of olfactory fear learning www.learnmem.org injections of scopolamine before training. Mice received the 0.5 mg/kg dose of scopolamine, as it was the lowest dose that significantly reduced freezing in the previous experiment. Mice displayed reduced freezing to E5 (44.45 + 5.4%, n ¼ 5), E4 (20.28 + 5.2%, n ¼ 9), and E6 (28.19 + 6.0%, n ¼ 12) (Fig. 3B) . No statically significant differences in freezing were observed across odor groups (ANOVA: F (2,23) ¼ 2.98, P ¼ 0.07), suggesting that pretraining scopolamine increases generalization.
We next tested whether increased muscarinic activation during learning could decrease generalization of olfactory fear. The experiment was repeated, except that in this case all mice received injections of the mAChR agonist oxotremorine before training to E5. Mice received injections of 0.05 mg/kg oxotremorine. Mice displayed freezing to E5 similar to saline controls (66.38 + 5.2%, n ¼ 9; t-test: t (15) ¼ 0.23, P ¼ 0.82) on the following day. Mice presented with E4 froze 7.2 + 2.0% (n ¼ 8) and mice presented with E6 froze 36.62 + 9.9% (n ¼ 10) (Fig. 3C) . Overall, a significant effect of the odor was detected by ANOVA (F (2,24) ¼ 16.12, P , 0.05) during the test session. Post hoc tests revealed a significant difference in freezing to E4 and E6 compared with E5, suggesting decreased generalization following increased muscarinic activation during learning.
It is possible that the reduction in learning was due to scopolamine directly disrupting olfactory sensitivity during training. To test whether the animal's ability to detect the odor was diminished with the drugs, we measured olfactory investigation times to E5 in naive mice following injections of saline, scopolamine (0.5 and 5 mg/kg), or oxotremorine + methyl scopolamine (0.05 mg/kg). Mice were placed in a cage with a 1-cm wooden bead containing filter paper saturated with 0.02 mL of E5 dissolved in mineral oil (1% vol/vol) in the center of the cage. For 1 min, the time each mouse spent investigating a 2-cm-diameter area surrounding the bead was recorded and analyzed using ANY-maze software (Stoelting). We found no significant differences in investigation times across groups, suggesting that the drugs did not significantly impact general olfactory abilities at the doses used here (ANOVA: F (3,28) ¼ 1.72, P ¼ 0.19) (saline: 3.45 + 0.3 sec; scop 0.5 mg/kg: 2.73 + 0.7 sec; scop 5 mg/kg: 2.25 + 0.7 sec; oxo + m-scop 0.5 mg/kg: 2.34 + 0.3).
Overall, we demonstrated that systemic mAChR, but not nAChR, blockade during acquisition reduces olfactory fear learning in mice. Furthermore, mice trained to associate E5 with foot shock express generalized fear responses toward the longer chained E6, but not toward the shorter chained E4 odor. Pretraining injections of a mAChR antagonist decreased subsequent fear responses to all odors, leading both to a reduction in learning and increase in generalization. Alternatively, pretraining injections of a muscarinic receptor agonist decreased generalization by decreasing freezing responses to both E4 and E6. Overall, these results suggest that mAChR activation during learning is needed for normal olfactory fear learning to occur.
Our results are consistent with previous studies demonstrating impaired olfactory learning following decreased cholinergic activation using other paradigms (Fletcher and Chen 2010) . However, our findings differ from olfactory reward-based studies in which animals with HDB lesions do not display any deficits in olfactory associative learning (Roman et al. 1993; Linster et al. 2001) . One explanation for this difference could be due to differences in the two associative learning paradigms used. It is possible that olfactory aversive learning might be more dependent on cholinergic modulation than appetitive learning. For example, a recent study using a similar olfactory aversion paradigm in rats also reported disruptions in olfactory learning following pretraining cholinergic blockade (Kroon and Carobrez 2009 ). This issue could be addressed in future studies by comparing the effects of HDB lesions on olfactory learning in mice trained in either olfactory reward or aversive conditioning.
Our results are similar to studies reporting reduced auditory fear learning following pretraining mAChR antagonist injections, but no effects following pretraining nAChR antagonists. Similar to our findings, the same pretraining doses of mecamylamine have no effect on auditory fear learning (Feiro and Gould 2005) . Additionally, several studies have reported that auditory fear conditioning is also impaired by pretraining scopolamine treatment (Young et al. 1995; Rudy 1996; Anagnostaras et al. 1999) .
Overall, there are several possibilities for the reduction in the learning that has been observed. For example, the blockade of mAChRs may attenuate olfactory sensitivity, alter sensitivity to the foot shock, and/or alter the odor-shock associative plasticity. Our odor investigation experiment along with another report (Doty et al. 2003) suggests that scopolamine does not significantly affect olfactory processing, at least with the odorant concentrations used here. A prior study has also demonstrated that systemic scopolamine does not affect foot-shock sensitivity in mice (Anagnostaras et al. 1999) . Thus, the observed impairment in fear conditioning is likely due to disruption of the neural mechanisms involved in olfactory associative learning itself.
In terms of associative conditioning, generalization refers to the tendency of the subject to respond to other stimuli that are Cholinergic modulation of olfactory fear learning www.learnmem.org similar to the learned stimulus. In most cases, the more a stimulus perceptually resembles the learned stimulus, the greater the response (Honig and Urcuioli 1981; McLaren and Mackintosh 2002) . By presenting an animal with odorants structurally similar to the trained odor and measuring freezing, we observed how much fear generalization occurred under our training conditions. Compared with E5, mice froze significantly less to E4 while freezing at similar levels to E6, suggesting that mice display significant generalization of their learned fear to E6. Pretraining scopolamine significantly increased this generalization as the difference in freezing between E5 and E4 was reduced following training. Thus, blocking muscarinic activation during learning not only reduces the strength of association, but also reduces the specificity of the learning. These results are consistent with a previous study demonstrating that pretraining scopolamine during olfactory aversive conditioning reduces learning-dependent olfactory acuity the following day (Fletcher and Wilson 2002) .
Other studies have also reported that a reduction in cholinergic activation during expression can increase generalization in odor-reward tasks (Linster et al. 2001; Linster and Cleland 2002) . However, in these studies, reduced cholinergic activation via HDB lesions was present during both the training and testing phases. Given that these animals displayed no deficits in acquiring the association, it likely that the increased generalization observed is due to the reduction in cholinergic activation during the test itself (Linster and Cleland 2002) . This together with the fact that cholinergic activity was only blocked during learning and not during testing in our study suggests that the cholinergic system plays an important role in both olfactory learning and subsequent recognition.
We also tested whether increased muscarinic activation during learning could lead to decreased generalization. Oxotremorine given prior to training significantly decreased freezing to E4 and E6 compared with E5. These results suggest that muscarinic enhancement during learning may increase the specificity of the learned stimulus. Interestingly, pretraining oxotremorine did not increase the strength of the association, suggesting that memory acuity can, at least in this case, be regulated independent of the strength of the memory. One potential issue with these results lies in the fact that higher doses of oxotremorine have been shown to have analgesic effects in mice (Wess et al. 2003) , making them less sensitive to the shock. However, this is likely not an issue here as our dose of oxotremorine was lower than the effective doses for inducing analgesia in the above study.
While these results demonstrate that olfactory generalization can be modulated by mAChRs during olfactory aversive learning, generalization can also be affected by other factors such as CS intensity, US intensity, and training conditions (Baldi et al. 2004; Cleland et al. 2009; Chen et al. 2011) . While our paradigm serves as the starting point for investigations into cholinergic influence on olfactory generalization, future experiments manipulating these factors are needed to fully characterize generalization of olfactory fear learning.
Given the global nature of the cholinergic block in this study, it is not possible to identify the affected brain regions that lead to the disruptions in learning reported here. All olfactory-related regions as well as fear-related regions such as the amygdala receive cholinergic input and are sites of interest. Given the numerous reports of cholinergic modulation of olfactory responses (Wilson 2001; Chaudhury et al. 2009; Ma and Luo 2012) , it is possible that AChR activation in olfactory areas plays an important role in the modulation of this type of learning. Future studies specifically targeting muscarinic cholinergic receptor activity in the olfactory bulb and piriform cortex during learning will be key in furthering our understanding of the role of acetylcholine in olfactory fear conditioning and generalization.
